- Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine MethodologyM F Rupnow
Department of Engineering Economic Systems and Operations Research, Stanford University, CA, USA
Helicobacter 4:272-80. 1999..We evaluated the cost-effectiveness (CE) of H. pylori vaccine development and use in the United States and developing countries, using a method developed by the Institute of Medicine (IOM)...
- A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United StatesM F Rupnow
Stanford University, Stanford, California, USA
Emerg Infect Dis 6:228-37. 2000..pylori has decreased to values so low that, should this trend continue, the organism will disappear from the population without targeted intervention; this process, however, will take more than a century...
- Quantifying the population impact of a prophylactic Helicobacter pylori vaccineM F Rupnow
Department of Management Science and Engineering, Stanford University, Stanford, CA 94305, USA
Vaccine 20:879-85. 2001..Helicobacter pylori vaccines, which have been suggested as promising interventions to control infection, are under development. We sought to quantify the potential population impact of a prophylactic H. pylori vaccine...